Displaying 1 to 20 of 40 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Alerion Biomedical Inc |
United States | N/A |
||
|
|
APT Pharmaceuticals Inc A pharmaceutical company focused on repurposing well-characterized drugs for under-served populations. |
United States | N/A |
||
|
|
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. |
United States | 1 Feb 2006 | Series B Initial investment. Round participant. Active |
|
|
|
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. |
United States | 1 Oct 2004 | Series A |
|
|
|
Clear Catheter Systems |
United States | N/A |
||
|
|
Clear Catheter Systems |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. |
United States | 31 Dec 2001 | Series A Initial investment. Round participant. Active |
|
|
|
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. |
United States | 1 Jan 2007 | Series C Initial investment. Round participant. Active |
|
|
|
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. |
United States | N/A |
||
|
|
Esperance Pharmaceuticals Inc Company that develops a new class of targeted anticancer drugs that selectively kill cancer cells without harming normal cells. |
United States | N/A |
||
|
|
Fullerene International Corp |
United States | N/A |
||
|
|
Fullerene International Corp |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Jenrin Discovery Inc Developer of drugs for the treatment of inflammatory and metabolic disorders, including obesity. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Jenrin Discovery Inc Developer of drugs for the treatment of inflammatory and metabolic disorders, including obesity. |
United States | N/A |
||
|
|
Kerberos Proximal Solutions Inc A medical device company that has developed products for improved vascular treatments. |
United States | N/A |
||
|
|
Kerberos Proximal Solutions Inc A medical device company that has developed products for improved vascular treatments. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
LaCoste & Romberg Scintrex Inc |
Canada | N/A Initial investment. Round participant. Active |
||
|
|
Lacoste & Romberg-Scintrex Inc |
Canada | N/A |
||
|
|
NP Photonics Inc |
United States | N/A |
||
|
|
NP Photonics Inc |
United States | N/A Initial investment. Round participant. Active |